Lv4
660 积分 2023-12-04 加入
STARGLO
6小时前
待确认
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
21天前
已完结
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929
21天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
25天前
已完结
Novel antibody-drug conjugates based on DXd-ADC technology
26天前
已完结
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
26天前
已完结
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
1个月前
已完结
Pancreatic cancer
1个月前
已完结
Soluble B7-H3 in Colorectal Cancer
1个月前
已完结
PSA Absolute Value Versus PSA Response Rate: Which Is More Valuable for Estimating Survival Outcomes With ARPI Treatment for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in Real-World Analyses?
1个月前
已完结
皖公网安备34019202002308
